Search Results
Results found for "richard leduc"
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Deviations—like reduced maximal responses or non-linear regressions—signal confounding kinetics, receptor Inverse Agonists and Hemi-Equilibria In systems with constitutive receptor activity , inverse agonists reduce
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Studying these routes may reduce side-effects when using GPCR-based therapies. Reduced background noise: Improvements in signal-to-noise ratio are key in CNS assays.
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
This compound has vastly reduced brain penetration and is devoid of significant off-target liability.
- Crinetics Presents Clinical And Research Results At ENDO 2022
Crinetics recently reported that administration of CRN04894 reduced both serum cortisol levels and 24
- 📰 GPCR Weekly News, March 4 to 10, 2024
Their research reveals how VU0486846 reduces neurogliosis in female Alzheimer's mice. Dr. Neuroscience A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
that SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher Education
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
By reducing receptor density, researchers can transform full agonists into partial ones—allowing comparative Model patient-like pathophysiological states (e.g., reduced receptor expression in heart failure).
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
Neutralization of the negatively charged extracellular pocket Ex1 destabilizes the cytosolic helical domain and reduces
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
In a LPS-induced lung inflammation model in mice, ACT-660602 led to significantly reduced recruitment
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
These effects include reducing the atherosclerotic plaque area, improving the serum lipid profile, attenuation
- Endogenous ligand recognition and structural transition of a human PTH receptor
physiological properties: PTH evokes prolonged Gs activation, whereas PTHrP evokes transient Gs activation with reduced
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
These effects include reducing the atherosclerotic plaque area, improving the serum lipid profile, attenuation
- Endogenous ligand recognition and structural transition of a human PTH receptor
physiological properties: PTH evokes prolonged Gs activation, whereas PTHrP evokes transient Gs activation with reduced
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
Def and Mrgpra2 mutant animals both exhibited skin dysbiosis, with reduced microbial diversity and expansion
- Dr. JoAnn Trejo - Dr. GPCR Podcast
Sharing how she became a scientist, educator, mentor, and the powerhouse we know today.
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Administration of Exendin-4 to MI rats reduced the infarct size and reversed the aforementioned signaling increased mRNA levels of MnSOD, protein levels of β-arrestin-2 and PP2A, and β-catenin phosphorylation but reduced β-arrestin-2 can stimulate PP2A to dephosphorylation Smad3 (inhibition) and GSK3β (activation), thus reduces
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Registration deadline: October 25, 2024 🔥 Why You Should Enroll Now: Cost-effective & Distinctive Educational Our goal is to ensure that education is within reach for everyone!
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
, small chemicals, hormones, cytokines, and, recently, gene editing techniques, have been tested to reduce
- GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation
CLH536, a novel GPR84 antagonist discovered by us, suppresses colitis by reducing the polarization and
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
. 📌 Reasons to Consider Enrolling Now: Exceptional Educational Opportunities at Unbeatable Value Our We aim to make education accessible to all!
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
intranasal infection with MCMV M33ΔC38, the absence of M33 CREB Gq/11-dependent signalling correlated with reduced mobilisation of lytically-infected DC to draining lymph node high endothelial venules (HEVs) and reduced
- Accelerating GPCR Drug Discovery
tracking to data workflows, I design simple, scalable tools that surface insights early and dramatically reduce
- PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
devoid of lysine, as well as serine/threonine residues, exhibits low levels of β-catenin and a markedly reduced
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
In a proof-of-principle study, we succeeded in showing that our CCR9-PROTAC is able to reduce CCR9 levels
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Separate effect size from time: Use allosteric modulators to expand therapeutic index and reduce overdose GPCR workflows, discovery teams can accelerate identification, characterization, and lead optimization—reducing
- GPCR Buzz of the Week | Sep 23 - 29, 2024
. 🔥 Why You Should Enroll Now: Budget-Friendly & Distinctive Educational Experience Affordable courses Our goal is to ensure that education is within reach for everyone!
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
We demonstrate that OGR1 protein expression is significantly reduced in lung tissue from patients with
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
Reducing the side chain size of I322 (MORI322A) transformed naloxone from an inhibitor directly into
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Terry Kenakin's educational initiative this fall!
- TLR4 biased small molecule modulators
potential therapeutic benefits, including greater pharmacodynamic specificity, increased efficiency and reduced











